by Peter Ciszewski | Jul 20, 2020
Jonathan Sorof, MD, Head of Medical Affairs at Global Blood Therapeutics (GBT) talks about the way patients with sickle cell disease have been affected by the COVID-19 pandemic. Sickle cell disease, as described by the NIH, is an inherited blood disorder....
by Peter Ciszewski | Jul 17, 2020
John Leonard, MD of Weill Cornell Medicine discusses follicular lymphoma. As described by the NIH, follicular lymphoma is the second most common non-Hodgkin lymphoma accounting for approximately 15% of all lymphomas in North America. Presentation of follicular...
by Peter Ciszewski | Jul 16, 2020
Recently, the US Food and Drug Administration (FDA) provided clearance to proceed with a Phase 2 clinical trial assessing HST5040 to treat children with propionic acidemia and methylmalonic acidemia, two rare inborn error of metabolism conditions that have limited...
by Peter Ciszewski | Jul 15, 2020
Ashish Sagrolikar, Chief Commercial Officer of Zogenix, discusses the typical diagnostic journey for patients with Dravet syndrome. Dravet syndrome, according to the NIH, is a severe form of epilepsy which typically appears in the first year of life as...
by Peter Ciszewski | Jul 13, 2020
Silvio Gutkind, PhD of University of California San Diego discusses recent data presented at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II. The data presented comes from a preclinical trial investigating Verastem...
